Cargando...
M112. Clozapine Use in Early-Intervention Programs Across Canada
Background: Clozapine remains to this day the treatment of choice for people with schizophrenia who have failed to respond to 2 consecutive antipsychotic trials. It is estimated that approximately 20% of first-episode psychotic patients fail to respond adequately to 2 consecutive antipsychotic trial...
Guardado en:
| Publicado en: | Schizophr Bull |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5476009/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx022.107 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|